Bintrafusp alfa plus paclitaxel for advanced gastric cancer as a second-line treatment: An open label, single-arm, phase Ib/II study.

被引：0
|
作者：
Lee, Choong-kun
Jung, Minkyu
Park, Sejung
Kwon, Woo Sun
Kim, Kyoo Hyun
Hong, Moonki
Kim, Hyunwook
Kim, Hyo Song
Chung, Hyun Cheol Cheol
Rha, Sun Young
机构：
[1] Yonsei Univ, Coll Med, Dept Internal Med, Div Med Oncol,Yonsei Canc Ctr, Seoul, South Korea
[2] Yonsei Univ, Coll Med, Songdang Inst Canc Res, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
374
引用
收藏
页码：374 / 374
页数：1
相关论文
共 50 条
  • [11] Toripalimab with nab-paclitaxel/gemcitabine as first-line treatment for advanced pancreatic adenocarcinoma: Updated results of a single-arm, open-label, phase Ib/II clinical study.
    Cheng, Ke
    Lv, Wan-Rui
    Li, Xiaofen
    Tian, Bole
    Cao, Dan
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [12] Second-line pemetrexed treatment in Taiwanese patients with advanced nonsmall cell lung cancer: An open-label single-arm study
    Chang, Gee-Chen
    Tsai, Chun-Ming
    Hsia, Te-Chun
    Yang, Chih-Hsin
    Abdulnabi, Radhi
    Blair, Julie M.
    Linn, Carlos
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2013, 112 (09) : 518 - 526
  • [13] A single-arm, open-label, prospective, multicenter study of apatinib combined with chemotherapy as second-line therapy in patients with advanced gastric cancer
    Feng, J.
    Shen, B.
    Xu, J.
    Wang, Q.
    Ling, G.
    Mao, Y.
    Cai, M.
    Yang, Y.
    Mei, J.
    Han, Z.
    Wu, Y.
    Shi, L.
    ANNALS OF ONCOLOGY, 2020, 31 : S913 - S913
  • [14] Efficacy and safety of anlotinib plus penpulimab as second-line treatment for small cell lung cancer: A multicenter, open-label, single-arm phase II trial
    Zhang, Changgong
    Chen, Jianhua
    Wu, Huijuan
    Wang, Jun
    Gao, Liying
    Zhao, Jun
    Sun, Yan
    Jia, Zhongyao
    Mu, Xinlin
    Bai, Chunmei
    Wang, Rui
    Wu, Kailiang
    Liu, Qiang
    Shi, Yuankai
    CANCER PATHOGENESIS AND THERAPY, 2024, 2 (04): : 268 - 275
  • [15] A phase Ib single-arm trial of bintrafusp alfa (BA) for pretreated, locally advanced/unresectable or metastatic (advanced) urothelial cancer (aUC)
    Grivas, P.
    Sridhar, S.
    Perez Valderrama, B.
    Castellano Gauna, D. E.
    Loriot, Y.
    Doger de Speville, B.
    Pouessel, D.
    van der Heijden, M. S.
    Galsky, M. D.
    Gulati, S.
    Ravaud, A.
    Fontana, E.
    Spira, A. I.
    Gartrell, B. A.
    Mortazavi, A.
    Isambert, N.
    Baxter, D.
    Powles, T. B.
    Khaled, A. H.
    Morales Barrera, R.
    ANNALS OF ONCOLOGY, 2023, 34 : S1209 - S1210
  • [16] Lenvatinib plus pembrolizumab in patients with advanced gastric cancer in the first-line or second-line setting (EPOC1706): an open-label, single-arm, phase 2 trial
    Kawazoe, Akihito
    Fukuoka, Shota
    Nakamura, Yoshiaki
    Kuboki, Yasutoshi
    Wakabayashi, Masashi
    Nomura, Shogo
    Mikamoto, Yuichi
    Shima, Hikari
    Fujishiro, Noriko
    Higuchi, Tsukiko
    Sato, Akihiro
    Kuwata, Takeshi
    Shitara, Kohei
    LANCET ONCOLOGY, 2020, 21 (08): : 1057 - 1065
  • [17] Multicenter phase I/II study of nivolumab combined with paclitaxel plus ramucirumab as the second-line treatment in patients with advanced gastric cancer
    Kadowaki, S.
    Izawa, N.
    Minashi, K.
    Nishina, T.
    Yamanaka, T.
    Muro, K.
    Sunakawa, Y.
    Hironaka, S.
    Kajiwara, T.
    Kawakami, Y.
    Nakajima, T.
    ANNALS OF ONCOLOGY, 2019, 30
  • [18] Multicenter Phase I/II Study of Nivolumab Combined with Paclitaxel Plus Ramucirumab as Second-line Treatment in Patients with Advanced Gastric Cancer
    Nakajima, Takako Eguchi
    Kadowaki, Shigenori
    Minashi, Keiko
    Nishina, Tomohiro
    Yamanaka, Takeharu
    Hayashi, Yuichiro
    Izawa, Naoki
    Muro, Kei
    Hironaka, Shuichi
    Kajiwara, Takeshi
    Kawakami, Yutaka
    CLINICAL CANCER RESEARCH, 2021, 27 (04) : 1029 - 1036
  • [19] Phase II study of sunitinib as second-line treatment for advanced gastric cancer
    Yung-Jue Bang
    Yoon-Koo Kang
    Won K. Kang
    Narikazu Boku
    Hyun C. Chung
    Jen-Shi Chen
    Toshihiko Doi
    Yan Sun
    Lin Shen
    Shukui Qin
    Wai-Tong Ng
    Jennifer M. Tursi
    Maria J. Lechuga
    Dongrui Ray Lu
    Ana Ruiz-Garcia
    Alberto Sobrero
    Investigational New Drugs, 2011, 29 : 1449 - 1458
  • [20] Phase II study of sunitinib as second-line treatment for advanced gastric cancer
    Bang, Yung-Jue
    Kang, Yoon-Koo
    Kang, Won K.
    Boku, Narikazu
    Chung, Hyun C.
    Chen, Jen-Shi
    Doi, Toshihiko
    Sun, Yan
    Shen, Lin
    Qin, Shukui
    Ng, Wai-Tong
    Tursi, Jennifer M.
    Lechuga, Maria J.
    Lu, Dongrui Ray
    Ruiz-Garcia, Ana
    Sobrero, Alberto
    INVESTIGATIONAL NEW DRUGS, 2011, 29 (06) : 1449 - 1458
12345